James  D'Arecca net worth and biography

James D'Arecca Biography and Net Worth

James C. D'Arecca serves as Chief Financial Officer of the Company. He served as Senior Vice President and Chief Accounting Officer of Allergan plc (formerly known as Actavis plc) from August 2013 until its merger with AbbVie Inc. in May 2020. Mr. D’Arecca was a key member of the finance team through Allergan’s journey from a generics manufacturer (Watson/Actavis) to a leading global pharmaceutical company. Mr. D’Arecca joined Actavis from Bausch & Lomb, where he served as its Chief Accounting Officer. Prior to Bausch & Lomb, Mr. D’Arecca served in various roles of increasing responsibility at Merck & Co. Inc. and Schering-Plough in finance and business development. He also spent 13 years with PricewaterhouseCoopers, with an industry focus on pharmaceuticals, medical devices, and consumer products. Mr. D’Arecca holds an M.B.A. from Columbia University and a B.S. in accounting from Rutgers University. He is a Certified Public Accountant.

How do I contact James D'Arecca?

The corporate mailing address for Mr. D'Arecca and other TherapeuticsMD executives is 951 Yamato Road Suite 220, BOCA RATON FL, 33431. TherapeuticsMD can also be reached via phone at (561) 961-1900 and via email at [email protected]. Learn More on James D'Arecca's contact information.

Has James D'Arecca been buying or selling shares of TherapeuticsMD?

James D'Arecca has not been actively trading shares of TherapeuticsMD during the last ninety days. Most recently, James Darecca sold 93,337 shares of the business's stock in a transaction on Thursday, August 12th. The shares were sold at an average price of $0.87, for a transaction totalling $81,203.19. Learn More on James D'Arecca's trading history.

Who are TherapeuticsMD's active insiders?

TherapeuticsMD's insider roster includes Paul Bisaro (Director), Edward Borkowski (EVP), Cooper Collins (Director), James D'Arecca (CFO), Michael Donegan (CAO), Robert Finizio (CEO), Tommy Thompson (Director), and Marlan Walker (General Counsel). Learn More on TherapeuticsMD's active insiders.

Are insiders buying or selling shares of TherapeuticsMD?

In the last twelve months, insiders at the sold shares 2 times. They sold a total of 15,670 shares worth more than $37,765.50. The most recent insider tranaction occured on December, 6th when CEO Marlan D Walker sold 14,500 shares worth more than $33,495.00. Insiders at TherapeuticsMD own 1.2% of the company. Learn More about insider trades at TherapeuticsMD.

Information on this page was last updated on 12/6/2023.

James D'Arecca Insider Trading History at TherapeuticsMD

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/12/2021Sell93,337$0.87$81,203.19View SEC Filing Icon  
See Full Table

James D'Arecca Buying and Selling Activity at TherapeuticsMD

This chart shows James Darecca's buying and selling at TherapeuticsMD by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

TherapeuticsMD Company Overview

TherapeuticsMD logo
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Read More

Today's Range

Now: $2.29
Low: $2.25
High: $2.31

50 Day Range

MA: $2.31
Low: $2.23
High: $2.69

2 Week Range

Now: $2.29
Low: $1.95
High: $4.72

Volume

9,722 shs

Average Volume

18,652 shs

Market Capitalization

$24.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03